Global Software as a Medical Device- Market

Software as a Medical Device- Comprehensive Study by Application (Medical Record, Patient Record, Training, Diagnosis, Medical Research, Others), Deployment Type (Cloud-based, On-premise, Hybrid), End-User (Hospitals & Clinics, Home Healthcare, Research Institutions, Pharmaceutical Companies, Others), Regulatory Class (Class I, Class II, Class III), Modality (Imaging & Diagnostics (Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), Computer-aided Detection (CAD), Telemedicine Platforms, Medical imaging software, Diagnostic Tools, Disease Management Tools, Others), Therapy Management (Remote Patient Monitoring (RPM), Medication Management Software, Clinical Decision Support Systems (CDSS), Others)) Players and Region - Global Market Outlook to 2032

Software as a Medical Device- Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Software as a medical device is intended to use for one or more medical purposes that perform these purposes without being part of a hardware medical device. The software can be used around a broad range of technology platforms, such as medical device platforms, commercial off-the-shelf platforms, and virtual networks, to name a few.This growth is primarily driven by Increasing Number of Healthcare Facilities .

AttributesDetails
Study Period2020-2032
Base Year2024
Forecast Period2025-2032
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Internet Software & Services sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Medtronic (Ireland), Johnson & Johnson (United States), ABBOTT (United States), Philips (Netherlands), Fresenius Medical Care (Germany), GE Healthcare (United States), BD (United States), Siemens Healthineers (Germany), Cardinal Health (United States) and Stryker Corporation (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 10th Jan 2022, Medtronic announced it has entered into a definitive agreement to acquire Affera, Inc. The acquisition will expand the Medtronic portfolio of advanced cardiac ablation products and accessories to meet physicians’ needs within a growing patient population. and On 10th Jan 2022, Johnson & Johnson announced it will collaborate with Microsoft to further allow and expand Johnson & Johnson’s secure and compliant digital surgery ecosystem. The Microsoft cloud will help Johnson & Johnson realize its vision of driving innovation that advances skills, improves workflow, and enhances surgical decision-making for a better overall customer experience and improved patient and economic outcomes.
Global Software as a Medical Device- is a fragmented market due to the presence of various players. The players are focusing on investing more in Launching New Games. These will enhance their market presence. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.

Influencing Trend:
Increasing Healthcare Expenditure

Market Growth Drivers:
Increasing Number of Healthcare Facilities and Aging Population is the Major Growth Factor for a Medical Device Software

Opportunities:
Growing Demand for Software as a Medical Device in Healthcare Sector

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Software as a Medical Device- Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Software as a Medical Device- Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Software as a Medical Device- players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Software as a Medical Device- Study Sheds Light on
— The Software as a Medical Device- Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Software as a Medical Device- industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Software as a Medical Device- industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Medical Record
  • Patient Record
  • Training
  • Diagnosis
  • Medical Research
  • Others
By Deployment Type
  • Cloud-based
  • On-premise
  • Hybrid

By End-User
  • Hospitals & Clinics
  • Home Healthcare
  • Research Institutions
  • Pharmaceutical Companies
  • Others

By Regulatory Class
  • Class I
  • Class II
  • Class III

By Modality
  • Imaging & Diagnostics (Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), Computer-aided Detection (CAD), Telemedicine Platforms, Medical imaging software, Diagnostic Tools, Disease Management Tools, Others)
  • Therapy Management (Remote Patient Monitoring (RPM), Medication Management Software, Clinical Decision Support Systems (CDSS), Others)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Healthcare Facilities
      • 3.2.2. Aging Population is the Major Growth Factor for a Medical Device Software
    • 3.3. Market Trends
      • 3.3.1. Increasing Healthcare Expenditure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Software as a Medical Device-, by Application, Deployment Type, End-User, Regulatory Class, Modality and Region (value and price ) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Software as a Medical Device- (Value)
      • 5.2.1. Global Software as a Medical Device- by: Application (Value)
        • 5.2.1.1. Medical Record
        • 5.2.1.2. Patient Record
        • 5.2.1.3. Training
        • 5.2.1.4. Diagnosis
        • 5.2.1.5. Medical Research
        • 5.2.1.6. Others
      • 5.2.2. Global Software as a Medical Device- by: Deployment Type (Value)
        • 5.2.2.1. Cloud-based
        • 5.2.2.2. On-premise
        • 5.2.2.3. Hybrid
      • 5.2.3. Global Software as a Medical Device- by: End-User (Value)
        • 5.2.3.1. Hospitals & Clinics
        • 5.2.3.2. Home Healthcare
        • 5.2.3.3. Research Institutions
        • 5.2.3.4. Pharmaceutical Companies
        • 5.2.3.5. Others
      • 5.2.4. Global Software as a Medical Device- by: Regulatory Class (Value)
        • 5.2.4.1. Class I
        • 5.2.4.2. Class II
        • 5.2.4.3. Class III
      • 5.2.5. Global Software as a Medical Device- by: Modality (Value)
        • 5.2.5.1. Imaging & Diagnostics (Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), Computer-aided Detection (CAD), Telemedicine Platforms, Medical imaging software, Diagnostic Tools, Disease Management Tools, Others)
        • 5.2.5.2. Therapy Management (Remote Patient Monitoring (RPM), Medication Management Software, Clinical Decision Support Systems (CDSS), Others)
      • 5.2.6. Global Software as a Medical Device- Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Australia
          • 5.2.6.2.6. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Software as a Medical Device- (Price)
  • 6. Software as a Medical Device-: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson & Johnson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ABBOTT (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Philips (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fresenius Medical Care (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GE Healthcare (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BD (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Siemens Healthineers (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cardinal Health (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Stryker Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Software as a Medical Device- Sale, by Application, Deployment Type, End-User, Regulatory Class, Modality and Region (value and price ) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Software as a Medical Device- (Value)
      • 7.2.1. Global Software as a Medical Device- by: Application (Value)
        • 7.2.1.1. Medical Record
        • 7.2.1.2. Patient Record
        • 7.2.1.3. Training
        • 7.2.1.4. Diagnosis
        • 7.2.1.5. Medical Research
        • 7.2.1.6. Others
      • 7.2.2. Global Software as a Medical Device- by: Deployment Type (Value)
        • 7.2.2.1. Cloud-based
        • 7.2.2.2. On-premise
        • 7.2.2.3. Hybrid
      • 7.2.3. Global Software as a Medical Device- by: End-User (Value)
        • 7.2.3.1. Hospitals & Clinics
        • 7.2.3.2. Home Healthcare
        • 7.2.3.3. Research Institutions
        • 7.2.3.4. Pharmaceutical Companies
        • 7.2.3.5. Others
      • 7.2.4. Global Software as a Medical Device- by: Regulatory Class (Value)
        • 7.2.4.1. Class I
        • 7.2.4.2. Class II
        • 7.2.4.3. Class III
      • 7.2.5. Global Software as a Medical Device- by: Modality (Value)
        • 7.2.5.1. Imaging & Diagnostics (Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), Computer-aided Detection (CAD), Telemedicine Platforms, Medical imaging software, Diagnostic Tools, Disease Management Tools, Others)
        • 7.2.5.2. Therapy Management (Remote Patient Monitoring (RPM), Medication Management Software, Clinical Decision Support Systems (CDSS), Others)
      • 7.2.6. Global Software as a Medical Device- Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Australia
          • 7.2.6.2.6. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Software as a Medical Device- (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Software as a Medical Device-: by Application(USD Million)
  • Table 2. Software as a Medical Device- Medical Record , by Region USD Million (2019-2024)
  • Table 3. Software as a Medical Device- Patient Record , by Region USD Million (2019-2024)
  • Table 4. Software as a Medical Device- Training , by Region USD Million (2019-2024)
  • Table 5. Software as a Medical Device- Diagnosis , by Region USD Million (2019-2024)
  • Table 6. Software as a Medical Device- Medical Research , by Region USD Million (2019-2024)
  • Table 7. Software as a Medical Device- Others , by Region USD Million (2019-2024)
  • Table 8. Software as a Medical Device-: by Deployment Type(USD Million)
  • Table 9. Software as a Medical Device- Cloud-based , by Region USD Million (2019-2024)
  • Table 10. Software as a Medical Device- On-premise , by Region USD Million (2019-2024)
  • Table 11. Software as a Medical Device- Hybrid , by Region USD Million (2019-2024)
  • Table 12. Software as a Medical Device-: by End-User(USD Million)
  • Table 13. Software as a Medical Device- Hospitals & Clinics , by Region USD Million (2019-2024)
  • Table 14. Software as a Medical Device- Home Healthcare , by Region USD Million (2019-2024)
  • Table 15. Software as a Medical Device- Research Institutions , by Region USD Million (2019-2024)
  • Table 16. Software as a Medical Device- Pharmaceutical Companies , by Region USD Million (2019-2024)
  • Table 17. Software as a Medical Device- Others , by Region USD Million (2019-2024)
  • Table 18. Software as a Medical Device-: by Regulatory Class(USD Million)
  • Table 19. Software as a Medical Device- Class I , by Region USD Million (2019-2024)
  • Table 20. Software as a Medical Device- Class II , by Region USD Million (2019-2024)
  • Table 21. Software as a Medical Device- Class III , by Region USD Million (2019-2024)
  • Table 22. Software as a Medical Device-: by Modality(USD Million)
  • Table 23. Software as a Medical Device- Imaging & Diagnostics (Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), Computer-aided Detection (CAD), Telemedicine Platforms, Medical imaging software, Diagnostic Tools, Disease Management Tools, Others) , by Region USD Million (2019-2024)
  • Table 24. Software as a Medical Device- Therapy Management (Remote Patient Monitoring (RPM), Medication Management Software, Clinical Decision Support Systems (CDSS), Others) , by Region USD Million (2019-2024)
  • Table 25. South America Software as a Medical Device-, by Country USD Million (2019-2024)
  • Table 26. South America Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 27. South America Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 28. South America Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 29. South America Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 30. South America Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 31. Brazil Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 32. Brazil Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 33. Brazil Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 34. Brazil Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 35. Brazil Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 36. Argentina Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 37. Argentina Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 38. Argentina Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 39. Argentina Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 40. Argentina Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 41. Rest of South America Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 42. Rest of South America Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 43. Rest of South America Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 44. Rest of South America Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 45. Rest of South America Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 46. Asia Pacific Software as a Medical Device-, by Country USD Million (2019-2024)
  • Table 47. Asia Pacific Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 48. Asia Pacific Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 49. Asia Pacific Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 50. Asia Pacific Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 51. Asia Pacific Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 52. China Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 53. China Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 54. China Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 55. China Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 56. China Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 57. Japan Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 58. Japan Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 59. Japan Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 60. Japan Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 61. Japan Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 62. India Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 63. India Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 64. India Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 65. India Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 66. India Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 67. South Korea Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 68. South Korea Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 69. South Korea Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 70. South Korea Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 71. South Korea Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 72. Australia Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 73. Australia Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 74. Australia Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 75. Australia Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 76. Australia Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 77. Rest of Asia-Pacific Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 78. Rest of Asia-Pacific Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 79. Rest of Asia-Pacific Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 80. Rest of Asia-Pacific Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 81. Rest of Asia-Pacific Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 82. Europe Software as a Medical Device-, by Country USD Million (2019-2024)
  • Table 83. Europe Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 84. Europe Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 85. Europe Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 86. Europe Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 87. Europe Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 88. Germany Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 89. Germany Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 90. Germany Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 91. Germany Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 92. Germany Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 93. France Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 94. France Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 95. France Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 96. France Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 97. France Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 98. Italy Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 99. Italy Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 100. Italy Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 101. Italy Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 102. Italy Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 103. United Kingdom Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 104. United Kingdom Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 105. United Kingdom Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 106. United Kingdom Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 107. United Kingdom Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 108. Netherlands Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 109. Netherlands Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 110. Netherlands Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 111. Netherlands Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 112. Netherlands Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 113. Rest of Europe Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 114. Rest of Europe Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 115. Rest of Europe Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 116. Rest of Europe Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 117. Rest of Europe Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 118. MEA Software as a Medical Device-, by Country USD Million (2019-2024)
  • Table 119. MEA Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 120. MEA Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 121. MEA Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 122. MEA Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 123. MEA Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 124. Middle East Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 125. Middle East Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 126. Middle East Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 127. Middle East Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 128. Middle East Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 129. Africa Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 130. Africa Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 131. Africa Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 132. Africa Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 133. Africa Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 134. North America Software as a Medical Device-, by Country USD Million (2019-2024)
  • Table 135. North America Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 136. North America Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 137. North America Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 138. North America Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 139. North America Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 140. United States Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 141. United States Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 142. United States Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 143. United States Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 144. United States Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 145. Canada Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 146. Canada Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 147. Canada Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 148. Canada Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 149. Canada Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 150. Mexico Software as a Medical Device-, by Application USD Million (2019-2024)
  • Table 151. Mexico Software as a Medical Device-, by Deployment Type USD Million (2019-2024)
  • Table 152. Mexico Software as a Medical Device-, by End-User USD Million (2019-2024)
  • Table 153. Mexico Software as a Medical Device-, by Regulatory Class USD Million (2019-2024)
  • Table 154. Mexico Software as a Medical Device-, by Modality USD Million (2019-2024)
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Software as a Medical Device-: by Application(USD Million)
  • Table 166. Software as a Medical Device- Medical Record , by Region USD Million (2027-2032)
  • Table 167. Software as a Medical Device- Patient Record , by Region USD Million (2027-2032)
  • Table 168. Software as a Medical Device- Training , by Region USD Million (2027-2032)
  • Table 169. Software as a Medical Device- Diagnosis , by Region USD Million (2027-2032)
  • Table 170. Software as a Medical Device- Medical Research , by Region USD Million (2027-2032)
  • Table 171. Software as a Medical Device- Others , by Region USD Million (2027-2032)
  • Table 172. Software as a Medical Device-: by Deployment Type(USD Million)
  • Table 173. Software as a Medical Device- Cloud-based , by Region USD Million (2027-2032)
  • Table 174. Software as a Medical Device- On-premise , by Region USD Million (2027-2032)
  • Table 175. Software as a Medical Device- Hybrid , by Region USD Million (2027-2032)
  • Table 176. Software as a Medical Device-: by End-User(USD Million)
  • Table 177. Software as a Medical Device- Hospitals & Clinics , by Region USD Million (2027-2032)
  • Table 178. Software as a Medical Device- Home Healthcare , by Region USD Million (2027-2032)
  • Table 179. Software as a Medical Device- Research Institutions , by Region USD Million (2027-2032)
  • Table 180. Software as a Medical Device- Pharmaceutical Companies , by Region USD Million (2027-2032)
  • Table 181. Software as a Medical Device- Others , by Region USD Million (2027-2032)
  • Table 182. Software as a Medical Device-: by Regulatory Class(USD Million)
  • Table 183. Software as a Medical Device- Class I , by Region USD Million (2027-2032)
  • Table 184. Software as a Medical Device- Class II , by Region USD Million (2027-2032)
  • Table 185. Software as a Medical Device- Class III , by Region USD Million (2027-2032)
  • Table 186. Software as a Medical Device-: by Modality(USD Million)
  • Table 187. Software as a Medical Device- Imaging & Diagnostics (Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), Computer-aided Detection (CAD), Telemedicine Platforms, Medical imaging software, Diagnostic Tools, Disease Management Tools, Others) , by Region USD Million (2027-2032)
  • Table 188. Software as a Medical Device- Therapy Management (Remote Patient Monitoring (RPM), Medication Management Software, Clinical Decision Support Systems (CDSS), Others) , by Region USD Million (2027-2032)
  • Table 189. South America Software as a Medical Device-, by Country USD Million (2027-2032)
  • Table 190. South America Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 191. South America Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 192. South America Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 193. South America Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 194. South America Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 195. Brazil Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 196. Brazil Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 197. Brazil Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 198. Brazil Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 199. Brazil Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 200. Argentina Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 201. Argentina Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 202. Argentina Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 203. Argentina Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 204. Argentina Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 205. Rest of South America Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 206. Rest of South America Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 207. Rest of South America Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 208. Rest of South America Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 209. Rest of South America Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 210. Asia Pacific Software as a Medical Device-, by Country USD Million (2027-2032)
  • Table 211. Asia Pacific Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 212. Asia Pacific Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 213. Asia Pacific Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 214. Asia Pacific Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 215. Asia Pacific Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 216. China Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 217. China Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 218. China Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 219. China Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 220. China Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 221. Japan Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 222. Japan Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 223. Japan Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 224. Japan Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 225. Japan Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 226. India Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 227. India Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 228. India Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 229. India Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 230. India Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 231. South Korea Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 232. South Korea Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 233. South Korea Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 234. South Korea Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 235. South Korea Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 236. Australia Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 237. Australia Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 238. Australia Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 239. Australia Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 240. Australia Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 241. Rest of Asia-Pacific Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 242. Rest of Asia-Pacific Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 243. Rest of Asia-Pacific Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 244. Rest of Asia-Pacific Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 245. Rest of Asia-Pacific Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 246. Europe Software as a Medical Device-, by Country USD Million (2027-2032)
  • Table 247. Europe Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 248. Europe Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 249. Europe Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 250. Europe Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 251. Europe Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 252. Germany Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 253. Germany Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 254. Germany Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 255. Germany Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 256. Germany Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 257. France Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 258. France Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 259. France Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 260. France Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 261. France Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 262. Italy Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 263. Italy Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 264. Italy Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 265. Italy Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 266. Italy Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 267. United Kingdom Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 268. United Kingdom Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 269. United Kingdom Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 270. United Kingdom Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 271. United Kingdom Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 272. Netherlands Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 273. Netherlands Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 274. Netherlands Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 275. Netherlands Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 276. Netherlands Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 277. Rest of Europe Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 278. Rest of Europe Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 279. Rest of Europe Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 280. Rest of Europe Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 281. Rest of Europe Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 282. MEA Software as a Medical Device-, by Country USD Million (2027-2032)
  • Table 283. MEA Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 284. MEA Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 285. MEA Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 286. MEA Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 287. MEA Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 288. Middle East Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 289. Middle East Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 290. Middle East Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 291. Middle East Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 292. Middle East Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 293. Africa Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 294. Africa Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 295. Africa Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 296. Africa Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 297. Africa Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 298. North America Software as a Medical Device-, by Country USD Million (2027-2032)
  • Table 299. North America Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 300. North America Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 301. North America Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 302. North America Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 303. North America Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 304. United States Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 305. United States Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 306. United States Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 307. United States Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 308. United States Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 309. Canada Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 310. Canada Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 311. Canada Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 312. Canada Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 313. Canada Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 314. Mexico Software as a Medical Device-, by Application USD Million (2027-2032)
  • Table 315. Mexico Software as a Medical Device-, by Deployment Type USD Million (2027-2032)
  • Table 316. Mexico Software as a Medical Device-, by End-User USD Million (2027-2032)
  • Table 317. Mexico Software as a Medical Device-, by Regulatory Class USD Million (2027-2032)
  • Table 318. Mexico Software as a Medical Device-, by Modality USD Million (2027-2032)
  • Table 319. Research Programs/Design for This Report
  • Table 320. Key Data Information from Secondary Sources
  • Table 321. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Software as a Medical Device-: by Application USD Million (2019-2024)
  • Figure 5. Global Software as a Medical Device-: by Deployment Type USD Million (2019-2024)
  • Figure 6. Global Software as a Medical Device-: by End-User USD Million (2019-2024)
  • Figure 7. Global Software as a Medical Device-: by Regulatory Class USD Million (2019-2024)
  • Figure 8. Global Software as a Medical Device-: by Modality USD Million (2019-2024)
  • Figure 9. South America Software as a Medical Device- Share (%), by Country
  • Figure 10. Asia Pacific Software as a Medical Device- Share (%), by Country
  • Figure 11. Europe Software as a Medical Device- Share (%), by Country
  • Figure 12. MEA Software as a Medical Device- Share (%), by Country
  • Figure 13. North America Software as a Medical Device- Share (%), by Country
  • Figure 14. Global Software as a Medical Device- share by Players 2024 (%)
  • Figure 15. Global Software as a Medical Device- share by Players (Top 3) 2024(%)
  • Figure 16. Global Software as a Medical Device- share by Players (Top 5) 2024(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 19. Medtronic (Ireland) Revenue: by Geography 2024
  • Figure 20. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 21. Johnson & Johnson (United States) Revenue: by Geography 2024
  • Figure 22. ABBOTT (United States) Revenue, Net Income and Gross profit
  • Figure 23. ABBOTT (United States) Revenue: by Geography 2024
  • Figure 24. Philips (Netherlands) Revenue, Net Income and Gross profit
  • Figure 25. Philips (Netherlands) Revenue: by Geography 2024
  • Figure 26. Fresenius Medical Care (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Fresenius Medical Care (Germany) Revenue: by Geography 2024
  • Figure 28. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 29. GE Healthcare (United States) Revenue: by Geography 2024
  • Figure 30. BD (United States) Revenue, Net Income and Gross profit
  • Figure 31. BD (United States) Revenue: by Geography 2024
  • Figure 32. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Siemens Healthineers (Germany) Revenue: by Geography 2024
  • Figure 34. Cardinal Health (United States) Revenue, Net Income and Gross profit
  • Figure 35. Cardinal Health (United States) Revenue: by Geography 2024
  • Figure 36. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 37. Stryker Corporation (United States) Revenue: by Geography 2024
  • Figure 38. Global Software as a Medical Device-: by Application USD Million (2027-2032)
  • Figure 39. Global Software as a Medical Device-: by Deployment Type USD Million (2027-2032)
  • Figure 40. Global Software as a Medical Device-: by End-User USD Million (2027-2032)
  • Figure 41. Global Software as a Medical Device-: by Regulatory Class USD Million (2027-2032)
  • Figure 42. Global Software as a Medical Device-: by Modality USD Million (2027-2032)
  • Figure 43. South America Software as a Medical Device- Share (%), by Country
  • Figure 44. Asia Pacific Software as a Medical Device- Share (%), by Country
  • Figure 45. Europe Software as a Medical Device- Share (%), by Country
  • Figure 46. MEA Software as a Medical Device- Share (%), by Country
  • Figure 47. North America Software as a Medical Device- Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Medtronic (Ireland)
  • Johnson & Johnson (United States)
  • ABBOTT (United States)
  • Philips (Netherlands)
  • Fresenius Medical Care (Germany)
  • GE Healthcare (United States)
  • BD (United States)
  • Siemens Healthineers (Germany)
  • Cardinal Health (United States)
  • Stryker Corporation (United States)
Select User Access Type

Key Highlights of Report


Jan 2025 220 Pages 97 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Software as a Medical Device- Market Quantitative research analysis
Global Software as a Medical Device- Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2020-2024; Base year: 2024; Forecast period: 2025 to 2032
Companies that are profiled in Global Software as a Medical Device- Market are Medtronic (Ireland), Johnson & Johnson (United States), ABBOTT (United States), Philips (Netherlands), Fresenius Medical Care (Germany), GE Healthcare (United States), BD (United States), Siemens Healthineers (Germany), Cardinal Health (United States) and Stryker Corporation (United States) etc.
Medical Record segment in Global market to hold robust market share owing to "Increasing Number of Healthcare Facilities ".

Know More About Global Software as a Medical Device- Market Report?

Have a Query? Click Here

Other Related Reports

Sound Effects Service Comprehensive Study by Type (Crowd Sound Effects, War Sound Effects, Foley Sound Effects, Train Sound Effects, Scary Sound Effects, Others), Application (Animation, Video Games,...
$ 3800
Diabetes Personal Software Comprehensive Study by Application (Hospitals, Clinics), Platforms (Smartphones, Desktop, Others), Deployment (Cloud-Based, Web-Based), Feature (Medication Reminder, Visual...
$ 3800
Brand Ambassador Solution Comprehensive Study by Application (Small & Medium Enterprise, Large Enterprise), Brand Ambassadors (Influencer ambassadors, Customer ambassadors, Affiliate ambassadors, Oth...
$ 3800
Ultra Reliable Low Latency Communications (URLLC) Comprehensive Study by Type (Release 15 Path, Release 16 Path, Others), Application (Industrial Internet, Smart Grids, Remote Surgery, Intelligent Tr...
$ 3800
Crypto Storage Wallets Comprehensive Study by Type (Hot Wallets (Desktop Wallets, Web Wallets, Mobile Wallets), Cold Wallets (Paper Wallets, Hardware Wallets)), Storage (Online, Offline), Cryptocurre...
$ 4000
Online Book Services Comprehensive Study by Type (EBooks, Audiobooks, Magazines, Others), Platform (Android, IOS, Web, Mac, Others), Subscription Type (Paid, Free) Players and Region - Global Market ...
$ 3400